Nonviral genome editing using CRISPR nanocomplexes and fabrication method thereof

Item Number: 610
Industry: Platform, Therapeutic
Category: Gene Therapy, Infectious Disease, Platform
Development Stage: Research
Organisation Type: Government Institute
Country: South Korea
Patent: Korea, PCT, USA, Europe
Business Opportunity: Out-Licensing, Collaboration R&D


The researchers achieved a major breakthrough by developing a method for forming CRISPR nanocomplexes consisting of a polymer-derivatized Cas9 protein, and guide RNA that target antibiotic resistance genes. 

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it